BUY Dr. Reddy's Laboratories Limited — Arpit Beriwal, Motilal Oswal
byArpit Beriwal, Motilal OswalHorizon: NA (inferred Swing (≤2wk))9 Jul 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·23 Jul · today
Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·22 Jul · today
Dr. Reddy's Laboratories will release its Q1FY27 financial results on Wednesday, July 22nd, 2026. An earnings call is scheduled for the same day to discuss financial performance.
NSE · Press Release·13 Jul · 1w ago
Dr. Reddy's Laboratories will announce its Q1FY27 financial results on Wednesday, July 22nd, 2026, followed by an earnings call at 19:30 PM IST.
BSE · Company Update·13 Jul · 1w ago
Dr. Reddy's Laboratories shares fall 7% as most analysts remain bearish after Q1 earnings miss
NewsCnbc-Tv18·23 Jul · today
Dr. Reddy's Laboratories shares will react to weak Q1 after US-listed ADR falls 10%
NewsCnbc-Tv18·23 Jul · today
Dr. Reddy's Laboratories shares will react to weak Q1 after US-listed ADR falls 10%
NewsCnbc-Tv18·23 Jul · today
Dr Reddy's Q1 Results: Semaglutide API provision weighs on profit; margin halves
NewsCnbc-Tv18·22 Jul · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.